London Daily

Focus on the big picture.
Wednesday, Nov 30, 2022

Pfizer accused of Covid profiteering as first-quarter sales hit $26bn

Pfizer accused of Covid profiteering as first-quarter sales hit $26bn

Pharma firm criticised over pricing and for keeping monopoly control over vaccine and new Paxlovid pill
*Your email address will not be displayed on website
This article does not have any comments yet.
London Daily
0:00
×